Thank you,
Sungwon Lim
We built this to say thank you. Everything on it is public and cited, and none of it came from anywhere you did not put it yourself.
He and Jamin Koo met as undergraduates and found a shared conviction, which became a company.
Sungwon Lim co-founded ImpriMed in 2017 on a specific bet: that the right cancer treatment should be chosen by testing a patient's own living cancer cells, not inferred from genetics alone. He completed his PhD at Stanford and advocates for functional precision medicine, personalising a regimen based on how each patient's cancer cells actually respond to anti-cancer drugs.
ImpriMed pairs quantitative high-throughput lab testing with machine learning to give clinicians a personalised drug prediction profile. In December 2023 the company closed a 23 million dollar Series A led by SBVA. By October 2025 it had processed its 10,000th live canine cancer cell sample, moved into a new Palo Alto laboratory, and begun preparing for CLIA certification.
Speaking at the AI Summit at Stanford on The Cure Is a Computation: AI and the Future of Healthcare.
This page exists to say thank you for showing up and doing the work in public. Every claim on it is cited below and checkable. The fuller picture our research put together is not published here, and will not be. It is yours the moment you claim it.
The record
Every line below is cited to a primary source you can open.
Co-founded ImpriMed in 2017 with Jamin Koo, and serves as Co-Founder, CEO and Board Director
ImpriMed, Inc.Closed a 23 million dollar Series A in December 2023, led by SBVA
ImpriMed, Inc.ImpriMed processed its 10,000th live canine cancer cell sample and moved to a new Palo Alto laboratory, preparing for CLIA certification
ImpriMed, Inc.
@sungwon-lim
This name is held for you.
This name is held for you, not by us. Claim it and the fuller model we researched becomes yours, on your own storage, for you to correct or delete.
There is more we found than is shown here. It is not published and it will not be. It is yours when you claim it.
Sign in and it is yours.
Sungwon, one tap is all this takes. Use an account you already have and @sungwon-lim is yours. Nothing new to sign up for, and no password to invent.
Signing in only proves the name is yours. Nothing is posted anywhere, nothing is shared, and it stays free.
Your 🤫 ID in Apple Wallet
Both cards, your spaceID and your 🤫 ID, are designed to live in Apple Wallet and Google Wallet so a check-in is a tap rather than a form.
Not yet issuable. A pass has to be signed with an Apple Pass Type ID certificate, and we do not hold one yet. The pass itself is built and waiting; we would rather say so than show you a button that quietly fails.
Not happy this exists?
Ask us to take this down and it goes, the same day, with nothing kept. Tell us and it is gone.
Where this came from
- Role and session read from the event programme, captured 31 July 2026, via AI Summit at Stanford
- Title, co-founders, founding year and company mission, via ImpriMed, Inc.
- Series A amount, investors and date, via ImpriMed, Inc.